Evidence map›Paper›PMID 38144407›Full record

ArticleCanadian liver journal2022

COVID-19 infection immediately post-transplant in an unvaccinated patient: Clinical observations and ethical implications.

Ben Cox, Trana Hussani, Vladimir Marquez, Mahmoud Omar, Maja Segedi, Eric M Yoshida

Open access · greenAbstract read
In one paragraph

Article in Canadian liver journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Hepatology in the time of COVID-19: Part 2.Canadian liver journal · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Ben CoxThe Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Trana HussaniFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
Vladimir MarquezThe Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Mahmoud OmarThe Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Maja SegediDepartment of Surgery, University of British Columbia, Vancouver, British Columbia, Canada.
Eric M YoshidaThe Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
University of British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the case of a 28-year-old woman who presented with acute liver failure from suspected drug-induced liver injury. She was not vaccinated against COVID-19 and expressed considerable reluctance to become vaccinated, prompting discussions within the transplant group regarding her candidacy. She received a liver transplant and acquired COVID-19 immediately post-operatively that was treated with sotrovimab. She recovered well and was discharged shortly following her transplant. This case suggests that unwillingness to receive COVID-19 vaccination pre-transplant should not represent an absolute contraindication to a life-saving liver transplantation.

Indexed as

COVID-19liver transplantationSars-CoV-2vaccine

Identifiers

PMID38144407
PMCPMC10735204
OpenAlexW4294816591

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.